Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

Xin-yue Lian; Zhi-hui Zhang; Zhao-qun Deng; Pin-fang He; Dong-ming Yao; Zi-jun Xu; Xiang-mei Wen; Lei Yang; Jiang Lin; Jun Qian

doi:10.1371/journal.pone.0165948

Loading metrics

Open Access

Peer-reviewed

Research Article

Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

Xin-yue Lian ,

Contributed equally to this work with: Xin-yue Lian, Zhi-hui Zhang

Affiliation Department of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Zhi-hui Zhang ,

Contributed equally to this work with: Xin-yue Lian, Zhi-hui Zhang

Affiliation Department of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Zhao-qun Deng,

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Pin-fang He,

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Dong-ming Yao,

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Zi-jun Xu,

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Xiang-mei Wen,

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Lei Yang,

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Jiang Lin ,

* E-mail: qianjun0007@hotmail.com (JQ); linjiangmail@sina.com (JL)

Affiliation Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯
Jun Qian

* E-mail: qianjun0007@hotmail.com (JQ); linjiangmail@sina.com (JL)

Affiliation Department of Hematology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
⨯

Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

Xin-yue Lian,
Zhi-hui Zhang,
Zhao-qun Deng,
Pin-fang He,
Dong-ming Yao,
Zi-jun Xu,
Xiang-mei Wen,
Lei Yang,
Jiang Lin,
Jun Qian

Published: November 8, 2016
https://doi.org/10.1371/journal.pone.0165948

Reader Comments (1)

Post a new comment on this article

0 Responses

15 Nov 2016
15:06 GMT
Most Recent

Excellent work ... How can I reach them by email ? Posted by ConstantineAdr on 15 Nov 2016 at 15:06 GMT

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cytogenetics
Is the Subject Area "Cytogenetics" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Acute myeloid leukemia
Is the Subject Area "Acute myeloid leukemia" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Neutropenia
Is the Subject Area "Neutropenia" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.
Thrombocytopenia
Is the Subject Area "Thrombocytopenia" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.